ArticleMolecular neurodegeneration2025

Cautions on utilizing plasma GFAP level as a biomarker for reactive astrocytes in neurodegenerative diseases.

Wongu Youn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.